guest ::
| Home > Publications database > Enhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1 > print |
| Home > Publications database > Enhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1 > print |
| 001 | 830254 | ||
| 005 | 20210129230447.0 | ||
| 024 | 7 | _ | |a 10.1016/j.jmb.2017.03.015 |2 doi |
| 024 | 7 | _ | |a WOS:000400720100006 |2 WOS |
| 024 | 7 | _ | |a altmetric:19219212 |2 altmetric |
| 024 | 7 | _ | |a pmid:28315663 |2 pmid |
| 037 | _ | _ | |a FZJ-2017-03827 |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |0 P:(DE-HGF)0 |a Vasudevan, Ananda Ayyappan Jaguva |b 0 |
| 245 | _ | _ | |a Enhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1 |
| 260 | _ | _ | |a Amsterdam [u.a.] |b Elsevier |c 2017 |
| 336 | 7 | _ | |2 DRIVER |a article |
| 336 | 7 | _ | |2 DataCite |a Output Types/Journal article |
| 336 | 7 | _ | |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |a Journal Article |b journal |m journal |s 1496057614_26299 |
| 336 | 7 | _ | |2 BibTeX |a ARTICLE |
| 336 | 7 | _ | |2 ORCID |a JOURNAL_ARTICLE |
| 336 | 7 | _ | |0 0 |2 EndNote |a Journal Article |
| 520 | _ | _ | |a The retroviral restriction factors of the APOBEC3 (A3) cytidine deaminase family catalyze the deamination of cytidines in single-stranded viral DNA. APOBEC3C (A3C) is a strong antiviral factor against viral infectivity factor (vif)-deficient simian immunodeficiency virus Δvif, which is, however, a weak inhibitor against human immunodeficiency virus (HIV)-1 for reasons unknown. The precise link between the antiretroviral effect of A3C and its catalytic activity is incompletely understood. Here, we show that the S61P mutation in human A3C (A3C.S61P) boosted hypermutation in the viral genomes of simian immunodeficiency virus Δvif and murine leukemia virus but not in human immunodeficiency virus HIV-1Δvif. The enhanced antiviral activity of A3C.S61P correlated with enhanced in vitro cytidine deamination. Furthermore, the S61P mutation did not change the substrate specificity of A3C, ribonucleoprotein complex formation, self-association, Zinc coordination, or viral incorporation features. We propose that local structural changes induced by the serine-to-proline substitution are responsible for the gain of catalytic activity of A3C.S61P. Our results are a first step toward an understanding of A3C's DNA binding capacity, deamination-dependent editing, and antiviral functions at the molecular level. We conclude that the enhanced enzymatic activity of A3C is insufficient to restrict HIV-1, indicating an unknown escape mechanism of HIV-1. |
| 536 | _ | _ | |0 G:(DE-HGF)POF3-553 |a 553 - Physical Basis of Diseases (POF3-553) |c POF3-553 |f POF III |x 0 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Hofmann, Henning |b 1 |
| 700 | 1 | _ | |0 P:(DE-Juel1)132029 |a Willbold, Dieter |b 2 |u fzj |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Häussinger, Dieter |b 3 |
| 700 | 1 | _ | |0 P:(DE-Juel1)132009 |a König, Bernd |b 4 |u fzj |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Münk, Carsten |b 5 |e Corresponding author |
| 773 | _ | _ | |0 PERI:(DE-600)1355192-9 |a 10.1016/j.jmb.2017.03.015 |n 8 |p 1171–1191 |t Journal of molecular biology |v 429 |x 0022-2836 |y 2017 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/830254/files/Enhancing%20the%20Catalytic%20Deamination%20Activity%20of%20APOBEC3C%20Is%20Insufficient%20to%20Inhibit%20Vif-Deficient%20HIV-1..pdf |y Restricted |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/830254/files/Enhancing%20the%20Catalytic%20Deamination%20Activity%20of%20APOBEC3C%20Is%20Insufficient%20to%20Inhibit%20Vif-Deficient%20HIV-1..gif?subformat=icon |x icon |y Restricted |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/830254/files/Enhancing%20the%20Catalytic%20Deamination%20Activity%20of%20APOBEC3C%20Is%20Insufficient%20to%20Inhibit%20Vif-Deficient%20HIV-1..jpg?subformat=icon-1440 |x icon-1440 |y Restricted |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/830254/files/Enhancing%20the%20Catalytic%20Deamination%20Activity%20of%20APOBEC3C%20Is%20Insufficient%20to%20Inhibit%20Vif-Deficient%20HIV-1..jpg?subformat=icon-180 |x icon-180 |y Restricted |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/830254/files/Enhancing%20the%20Catalytic%20Deamination%20Activity%20of%20APOBEC3C%20Is%20Insufficient%20to%20Inhibit%20Vif-Deficient%20HIV-1..jpg?subformat=icon-640 |x icon-640 |y Restricted |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/830254/files/Enhancing%20the%20Catalytic%20Deamination%20Activity%20of%20APOBEC3C%20Is%20Insufficient%20to%20Inhibit%20Vif-Deficient%20HIV-1..pdf?subformat=pdfa |x pdfa |y Restricted |
| 909 | C | O | |o oai:juser.fz-juelich.de:830254 |p VDB |
| 910 | 1 | _ | |0 I:(DE-HGF)0 |6 P:(DE-HGF)0 |a External Institute |b 0 |k Extern |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)132029 |a Forschungszentrum Jülich |b 2 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)132009 |a Forschungszentrum Jülich |b 4 |k FZJ |
| 913 | 1 | _ | |0 G:(DE-HGF)POF3-553 |1 G:(DE-HGF)POF3-550 |2 G:(DE-HGF)POF3-500 |a DE-HGF |b Key Technologies |l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |v Physical Basis of Diseases |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
| 914 | 1 | _ | |y 2017 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0420 |2 StatID |a Nationallizenz |
| 915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |
| 915 | _ | _ | |0 StatID:(DE-HGF)0310 |2 StatID |a DBCoverage |b NCBI Molecular Biology Database |
| 915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b J MOL BIOL : 2015 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |
| 915 | _ | _ | |0 StatID:(DE-HGF)0600 |2 StatID |a DBCoverage |b Ebsco Academic Search |
| 915 | _ | _ | |0 StatID:(DE-HGF)0030 |2 StatID |a Peer Review |b ASC |
| 915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |0 StatID:(DE-HGF)0110 |2 StatID |a WoS |b Science Citation Index |
| 915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |
| 915 | _ | _ | |0 StatID:(DE-HGF)0111 |2 StatID |a WoS |b Science Citation Index Expanded |
| 915 | _ | _ | |0 StatID:(DE-HGF)1030 |2 StatID |a DBCoverage |b Current Contents - Life Sciences |
| 915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |
| 915 | _ | _ | |0 StatID:(DE-HGF)9900 |2 StatID |a IF < 5 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)ICS-6-20110106 |k ICS-6 |l Strukturbiochemie |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| 980 | _ | _ | |a UNRESTRICTED |
| 981 | _ | _ | |a I:(DE-Juel1)IBI-7-20200312 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|